0001104659-17-041339.txt : 20170623
0001104659-17-041339.hdr.sgml : 20170623
20170623172041
ACCESSION NUMBER: 0001104659-17-041339
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170623
FILED AS OF DATE: 20170623
DATE AS OF CHANGE: 20170623
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aralez Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001660719
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7100 WEST CREDIT AVENUE, SUITE 101
CITY: MISSISSAUGA
STATE: A6
ZIP: L5N 0E4
BUSINESS PHONE: 905-876-1118
MAIL ADDRESS:
STREET 1: 7100 WEST CREDIT AVENUE, SUITE 101
CITY: MISSISSAUGA
STATE: A6
ZIP: L5N 0E4
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Trachtenberg Eric
CENTRAL INDEX KEY: 0001646300
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37691
FILM NUMBER: 17928448
MAIL ADDRESS:
STREET 1: 1414 RALEIGH ROAD
STREET 2: SUITE 400
CITY: CHAPEL HILL
STATE: NC
ZIP: 27517
4
1
a4.xml
4
X0306
4
2017-06-23
0
0001660719
Aralez Pharmaceuticals Inc.
ARLZ
0001646300
Trachtenberg Eric
C/O ARALEZ PHARMACEUTICALS INC.,
7100 WEST CREDIT AVENUE, SUITE 101
MISSISSAUGA
A6
L5N 0E4
ONTARIO, CANADA
0
1
0
0
GC, CCO & Secretary
Common Shares, without par value
2017-06-23
4
S
0
7720
1.33
D
201564
D
This represents shares sold by the issuer on behalf of the reporting person pursuant to an instruction made in accordance with Rule 10b5-1 for payment of withholding tax liability incurred upon the vesting of 25,000 restricted stock units, which vested on June 22, 2017. 6,250 of such restricted stock units were previously granted on June 22, 2015 and 18,750 of such restricted stock units were previously granted on February 12, 2016.
/s/ Eric L. Trachtenberg
2017-06-23